Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 7 | 2023 | 225 | 0.970 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2019 | 82 | 0.800 |
Why?
|
| Brain | 7 | 2023 | 769 | 0.470 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2014 | 34 | 0.430 |
Why?
|
| Aging | 4 | 2019 | 1016 | 0.390 |
Why?
|
| GTP-Binding Proteins | 6 | 1998 | 46 | 0.390 |
Why?
|
| Caspase 8 | 1 | 2011 | 10 | 0.370 |
Why?
|
| Sirolimus | 4 | 2013 | 76 | 0.360 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 39 | 0.350 |
Why?
|
| Epidermal Growth Factor | 2 | 2005 | 24 | 0.310 |
Why?
|
| Capsaicin | 2 | 2019 | 18 | 0.300 |
Why?
|
| Mouth Neoplasms | 2 | 2019 | 64 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2019 | 165 | 0.260 |
Why?
|
| Animals | 20 | 2023 | 10684 | 0.250 |
Why?
|
| Cerebrovascular Circulation | 2 | 2019 | 224 | 0.240 |
Why?
|
| Amino Acid Sequence | 8 | 2012 | 697 | 0.230 |
Why?
|
| Mitochondria | 2 | 2019 | 408 | 0.230 |
Why?
|
| TRPV Cation Channels | 3 | 2019 | 16 | 0.220 |
Why?
|
| Endometriosis | 1 | 2024 | 19 | 0.220 |
Why?
|
| Endometrium | 1 | 2024 | 39 | 0.220 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 1056 | 0.220 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 114 | 0.220 |
Why?
|
| Stromal Cells | 1 | 2024 | 62 | 0.220 |
Why?
|
| Blood Platelets | 2 | 2005 | 206 | 0.220 |
Why?
|
| Signal Transduction | 6 | 2017 | 1469 | 0.210 |
Why?
|
| Tauopathies | 1 | 2023 | 6 | 0.200 |
Why?
|
| Cell Movement | 1 | 2024 | 376 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 2 | 2015 | 49 | 0.190 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 1507 | 0.190 |
Why?
|
| Nanowires | 1 | 2021 | 5 | 0.170 |
Why?
|
| Macromolecular Substances | 1 | 2021 | 53 | 0.170 |
Why?
|
| Humans | 21 | 2024 | 28851 | 0.170 |
Why?
|
| Mice | 11 | 2023 | 4802 | 0.160 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 1996 | 4 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2013 | 515 | 0.150 |
Why?
|
| Cognition Disorders | 2 | 2012 | 186 | 0.150 |
Why?
|
| Isoquinolines | 1 | 2019 | 15 | 0.150 |
Why?
|
| Natural Springs | 1 | 2018 | 1 | 0.150 |
Why?
|
| Luteolin | 1 | 2018 | 3 | 0.150 |
Why?
|
| Cell Line | 8 | 2009 | 700 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 39 | 0.150 |
Why?
|
| Sesquiterpenes | 1 | 2018 | 22 | 0.150 |
Why?
|
| Sulfides | 1 | 2018 | 40 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 87 | 0.140 |
Why?
|
| Gram-Negative Bacteria | 1 | 2018 | 62 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 154 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2018 | 109 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2005 | 133 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 9 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2017 | 14 | 0.130 |
Why?
|
| Cloning, Molecular | 5 | 2005 | 208 | 0.130 |
Why?
|
| Guanine Nucleotides | 1 | 1996 | 4 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 634 | 0.130 |
Why?
|
| Calmodulin | 1 | 1996 | 9 | 0.130 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1996 | 6 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 79 | 0.120 |
Why?
|
| Phylogeny | 1 | 2018 | 490 | 0.120 |
Why?
|
| Transfection | 5 | 2014 | 319 | 0.120 |
Why?
|
| Protein Binding | 4 | 2017 | 667 | 0.120 |
Why?
|
| Memory | 2 | 2013 | 76 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 1996 | 120 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 271 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2013 | 585 | 0.120 |
Why?
|
| Apoptosis | 1 | 2019 | 780 | 0.120 |
Why?
|
| Phenotype | 2 | 2018 | 685 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2023 | 513 | 0.110 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 1350 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 1996 | 255 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 1996 | 187 | 0.110 |
Why?
|
| Receptor, trkA | 1 | 2014 | 11 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2012 | 150 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2013 | 20 | 0.100 |
Why?
|
| Sirtuins | 1 | 2013 | 17 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 275 | 0.100 |
Why?
|
| Rats | 4 | 2019 | 1588 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 55 | 0.100 |
Why?
|
| Cell Death | 2 | 2014 | 119 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 686 | 0.100 |
Why?
|
| DNA, Complementary | 3 | 2005 | 78 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 165 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2012 | 61 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 3 | 1998 | 19 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2012 | 57 | 0.090 |
Why?
|
| Kinetics | 5 | 2017 | 553 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2012 | 108 | 0.090 |
Why?
|
| Proteolysis | 1 | 2011 | 59 | 0.090 |
Why?
|
| RNA | 2 | 2018 | 111 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2018 | 824 | 0.090 |
Why?
|
| Longevity | 1 | 2012 | 141 | 0.090 |
Why?
|
| Base Sequence | 4 | 2012 | 588 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2023 | 373 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 68 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 1990 | 100 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1990 | 97 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 874 | 0.080 |
Why?
|
| tau Proteins | 2 | 2023 | 29 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 490 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2012 | 523 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 612 | 0.070 |
Why?
|
| Dopamine | 1 | 2009 | 24 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 536 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2009 | 80 | 0.070 |
Why?
|
| Stilbenes | 1 | 2009 | 91 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2019 | 332 | 0.070 |
Why?
|
| COS Cells | 2 | 2005 | 49 | 0.070 |
Why?
|
| Female | 6 | 2024 | 15624 | 0.070 |
Why?
|
| Guanosine Diphosphate | 3 | 1998 | 18 | 0.070 |
Why?
|
| Cell Survival | 2 | 2018 | 419 | 0.060 |
Why?
|
| Antioxidants | 1 | 2009 | 224 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 1996 | 32 | 0.060 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 1998 | 8 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 2 | 2017 | 37 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 21 | 0.060 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2005 | 15 | 0.060 |
Why?
|
| Peroxidase | 1 | 2005 | 39 | 0.060 |
Why?
|
| Biotin | 1 | 2005 | 25 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 43 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2005 | 57 | 0.060 |
Why?
|
| Serine | 1 | 2005 | 51 | 0.060 |
Why?
|
| Platelet Aggregation | 1 | 2005 | 44 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2024 | 5 | 0.060 |
Why?
|
| Tyrosine | 1 | 2005 | 92 | 0.060 |
Why?
|
| Platelet Activation | 1 | 2005 | 54 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 137 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2017 | 202 | 0.060 |
Why?
|
| Cell Communication | 1 | 2005 | 68 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 194 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 284 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 169 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 328 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2009 | 677 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2005 | 292 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 196 | 0.050 |
Why?
|
| Guanosine Triphosphate | 2 | 1996 | 29 | 0.050 |
Why?
|
| Cell Membrane | 3 | 1996 | 268 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 668 | 0.050 |
Why?
|
| Peptides | 1 | 2005 | 296 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 3 | 1998 | 17 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2013 | 391 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2023 | 141 | 0.050 |
Why?
|
| Platinum | 1 | 2021 | 18 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2021 | 67 | 0.040 |
Why?
|
| Graphite | 1 | 2021 | 12 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 3 | 1996 | 28 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 62 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 82 | 0.040 |
Why?
|
| Porphyrins | 1 | 2021 | 20 | 0.040 |
Why?
|
| Male | 4 | 2019 | 13921 | 0.040 |
Why?
|
| RNA Interference | 2 | 2012 | 137 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2000 | 33 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1998 | 46 | 0.040 |
Why?
|
| Virus Replication | 1 | 2000 | 66 | 0.040 |
Why?
|
| HIV-1 | 1 | 2000 | 58 | 0.040 |
Why?
|
| Proteins | 3 | 1998 | 254 | 0.040 |
Why?
|
| Mutation | 2 | 2014 | 867 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2018 | 25 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 30 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 19 | 0.040 |
Why?
|
| Phthalazines | 1 | 2018 | 25 | 0.040 |
Why?
|
| Piperazines | 1 | 2018 | 50 | 0.040 |
Why?
|
| Sodium Fluoride | 1 | 1998 | 1 | 0.040 |
Why?
|
| Metagenomics | 1 | 2018 | 57 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 209 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2018 | 245 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 416 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 303 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 554 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 1653 | 0.030 |
Why?
|
| Ultracentrifugation | 1 | 2017 | 8 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2017 | 20 | 0.030 |
Why?
|
| Protein Folding | 1 | 2017 | 47 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 73 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 66 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2012 | 66 | 0.030 |
Why?
|
| Spodoptera | 1 | 1996 | 4 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 57 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1996 | 42 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 45 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 119 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1996 | 68 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2013 | 267 | 0.030 |
Why?
|
| Fetus | 1 | 1996 | 79 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 117 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 472 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 465 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 477 | 0.030 |
Why?
|
| Oklahoma | 1 | 2018 | 1052 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 433 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 56 | 0.030 |
Why?
|
| Apolipoprotein E3 | 1 | 2013 | 12 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 96 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 39 | 0.030 |
Why?
|
| Nitroarginine | 1 | 2013 | 4 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2013 | 37 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 133 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2014 | 79 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2012 | 7 | 0.020 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 1992 | 1 | 0.020 |
Why?
|
| Biogenic Monoamines | 1 | 2012 | 3 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2012 | 8 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 36 | 0.020 |
Why?
|
| Vasodilation | 1 | 2013 | 115 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2012 | 15 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 153 | 0.020 |
Why?
|
| Cattle | 2 | 1992 | 389 | 0.020 |
Why?
|
| Maze Learning | 1 | 2012 | 78 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 251 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 247 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 467 | 0.020 |
Why?
|
| Thionucleotides | 1 | 1990 | 5 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1990 | 45 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 122 | 0.020 |
Why?
|
| Placenta | 1 | 1990 | 78 | 0.020 |
Why?
|
| Autophagy | 1 | 2010 | 77 | 0.020 |
Why?
|
| Liposomes | 1 | 1990 | 145 | 0.020 |
Why?
|
| Cinnamates | 1 | 2009 | 6 | 0.020 |
Why?
|
| Thiourea | 1 | 2009 | 17 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 43 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 80 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1613 | 0.020 |
Why?
|
| Pregnancy | 1 | 1990 | 1254 | 0.010 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2000 | 4 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2000 | 30 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2000 | 212 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2000 | 114 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1998 | 31 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1998 | 33 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 111 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1998 | 160 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 233 | 0.010 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 1992 | 1 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1992 | 14 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 355 | 0.010 |
Why?
|
| Moths | 1 | 1992 | 13 | 0.010 |
Why?
|
| Cytosol | 1 | 1992 | 49 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1992 | 338 | 0.000 |
Why?
|